IDBS, innovator in Biopharmaceutical Lifecycle Management (BPLM), and Scitara, expert in laboratory IoT, have partnered to create a solution that will extend IDBS Polar BPLM’s laboratory data connectivity and instrument integration capabilities. This solution boosts the Polar workflow capabilities by addressing the challenge of sharing and digitalising laboratory data across… Read More
High-throughput screening remains one of the most powerful, unbiased approaches for small molecule drug discovery. In this whitepaper, “Disrupting Drug Discovery From Assay Development to Lead Compound”, SAMDI Tech CSO, Zack Gurard-Levin, discusses the important aspects to consider when choosing the right methodology for drug discovery. The whitepaper covers traditional… Read More
High-throughput screening remains one of the most powerful, unbiased approaches for small molecule drug discovery. In this whitepaper, SAMDI Tech CSO, Zack Gurard-Levin, discusses the important aspects to consider when choosing the right methodology for drug discovery. Learn: Traditional label-dependent approaches vs. novel label-free technologies How researchers determine which methodology… Read More
Levels of antibodies in the blood of vaccinated people that can recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are on average lower than those against previously circulating variants in the UK, according to new laboratory data from the Francis Crick Institute and the National… Read More
Biopharmaceutical innovator Sanofi has launched a €3 million Planet Mobilisation fund to support employee ideas and projects that will further contribute to a healthier environment. In 2021, three Sanofi teams will have their projects implemented and funded. For several years, Sanofi has been implementing a global environmental roadmap, Planet Mobilisation,… Read More
Bruker has launched new products, as outlined June 1-3, 2021 at the eXceed Symposia 2021. The products include timsTOF trueSCP and timsTOF Pro 2. Mass spectrometric proteomics has become a staple of modern research in understanding biological function and disease mechanisms. Healthy or diseased tissues that seem homogenous are composed… Read More
Berkeley Lights has released its TechAccess Subscription model to enable broader customer access to their single-cell screening technology. The new offering brings requested volume and throughput flexibility to customers who want to access the company’s cell line development and antibody discovery workflows. The all-inclusive subscription provides customers with a comprehensive… Read More
University of Queensland scientists have successfully protected mice from the Covid-19 virus by administering a US-developed vaccine candidate with a ‘patch’, rather than a needle. The University of Texas Hexapro vaccine candidate, delivered via the UQ-developed and Vaxxas-commercialised high-density microarray patch (HD-MAP), provided protection against Covid-19 disease with a single,… Read More
Eli Lilly’s tirzepatide, a once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 receptor agonist (GLP-1RA), recently demonstrated that it was able to not only reduce HbA1c levels in type 2 diabetes (T2D) patients, but also confer weight loss when compared to insulin glargine in the SURPASS-4 trial. Tirzepatide… Read More
Women may have a stronger immune response to a common form of skin cancer than men, according to early research on mice and human cells. Led by University of Manchester scientists at the Cancer Research UK Manchester Institute, the team publish their findings in Clinical Cancer Research. Men have more… Read More
Researchers at the Francis Crick Institute have identified a protein that helps tumours evade the immune system and, in certain types of cancers, is linked to a poorer chance of survival. The protein could become a target for future cancer treatments. A crucial part of the immune system’s response to… Read More
Neo Kuma Ventures has invested in seven innovative healthcare companies. The initial investments have proved successful with three of the seven companies going public this year, yielding between +180% and +680% return on initial investment. Following the launch of its fund in December 2020, Neo Kuma has invested more than… Read More
An electron microscope, reported to break new ground in biological imaging, is being installed at the Franklin’s new building on Harwel Campus. The machine can image biological samples at up to a million frames per second, which is one thousand times faster than the current standard. It is the first… Read More
Aptamer and PinotBio have entered into a strategic collaboration agreement to develop Optimer-drug conjugates for targeted drug delivery, combining Aptamer’s Optimer technology with PinotBio’s technology using the chemotherapeutic FL-118 compound with specific linker. Optimer therapeutics are optimised aptamer solutions. Optimer-drug conjugates offer uniquely specific targeting vehicles for the delivery of… Read More
Moderna has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License Application (BLA) for the licensure of its mRNA COVID-19 Vaccine to prevent COVID-19 in individuals 18 years of age and older. Stéphane Bancel, Chief Executive Officer of Moderna, said: “We look forward… Read More
Samsung Biologics, a CDMO, plans to add mRNA vaccine drug substance (DS) manufacturing capability to its current facility in Songdo, ready for cGMP operations within early 2022. mRNA has been the technology of choice for many Covid-19 vaccines due to its characteristics of safety and fast scalability in manufacturing. “We… Read More
